FdaApplication
BLA 125431
Identifiers
- fda_app_no: BLA125431
Properties
| Property | Value |
|---|---|
| applicant_name | GlaxoSmithKline LLC |
| application_type | BLA |
| approval_date | 2014-04-15 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TANZEUM | ALBIGLUTIDE | 30MG | For Injection |
| TANZEUM | — | 50MG | For Injection |
2 products